Synovial Fluid C-reactive Protein as a Diagnostic Marker for Periprosthetic Joint Infection: A Systematic Review and Meta-analysis

Chi Wang, Qi Wang, Rui Li, Jin-Yan Duan, Cheng-Bin Wang, Chi Wang, Qi Wang, Rui Li, Jin-Yan Duan, Cheng-Bin Wang

Abstract

Background: Periprosthetic joint infection (PJI) is the main cause of failure following total joint arthroplasty. Until now, the diagnosis of PJI is still confronted with technical limitations, and the question of whether synovial fluid biomarker, C-reactive protein (CRP), can provide high value in the diagnosis of PJI remains unanswered and, therefore, was the aim of the study.

Methods: First, we conducted a systematic review on CRP in the diagnosis of PJI by searching online databases using keywords such as "periprosthetic joint infection", "synovial fluid", and "C-reactive protein". Eligible studies providing sufficient data to construct 2 × 2 contingency tables were then selected based on the list of criteria and the quality of included studies was assessed subsequently. Finally, the reported sensitivity, specificity, diagnostic odds ratio (DOR), summary receiver operating characteristic (SROC) curve, and the area under the SROC (AUSROC) were pooled together and used to evaluate overall diagnostic performance.

Results: Seven studies were included in our review, six of which comprising a total of 456 participants were further investigated in our meta-analysis. The pooled sensitivity, specificity, and DOR were 0.92 (95% confidence interval [CI]: 0.86-0.96), 0.90 (95% CI: 0.87-0.93), and 101.40 (95% CI: 48.07-213.93), respectively. The AUSROC was 0.9663 (standard error, 0.0113).

Conclusions: Synovial fluid CRP is a good biomarker for the diagnosis of PJI with high sensitivity and specificity.

Figures

Figure 1
Figure 1
Flowchart of the selection process for eligible studies.
Figure 2
Figure 2
Quality assessment of included studies using QUADAS-2 tool criteria. QUADAS-2: The revised Quality Assessment of Diagnostic Accuracy Studies.
Figure 3
Figure 3
Pooled sensitivity and specificity of CRP in the diagnosis of PJI. CRP: C-reactive protein; PJI: Periprosthetic joint infection.
Figure 4
Figure 4
Positive LR and negative LR of CRP in the diagnosis of PJI. LR: Likelihood ratio; CRP: C-reactive protein; PJI: Periprosthetic joint infection.
Figure 5
Figure 5
Summary of SROC of CRP in the diagnosis of PJI. SROC: Summarized receiver operating characteristics curve; CRP: C-reactive protein; PJI: Periprosthetic joint infection; SE: Standard error.

References

    1. Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468:45–51. doi: 10.1007/s11999-009-0945-0.
    1. Shearer DW, Youm J, Bozic KJ. Short-term complications have more effect on cost-effectiveness of THA than implant longevity. Clin Orthop Relat Res. 2015;473:1702–8. doi: 10.1007/s11999-014-4110-z.
    1. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med. 2009;361:787–94. doi: 10.1056/NEJMcp0905029.
    1. Garvin KL, Konigsberg BS. Infection following total knee arthroplasty: Prevention and management. J Bone Joint Surg Am. 2011;93:1167–75.
    1. Chen A, Fei J, Deirmegian C. Diagnosis of periprosthetic infection: Novel developments. J Knee Surg. 2014;27:259–65. doi: 10.1055/s-0034-1371768.
    1. Hayter CL, Koff MF, Potter HG. Magnetic resonance imaging of the postoperative hip. J Magn Reson Imaging. 2012;35:1013–25. doi: 10.1002/jmri.23523.
    1. Springer BD. The diagnosis of periprosthetic joint infection. J Arthroplasty. 2015;30:908–11. doi: 10.1016/j.arth.2015.03.042.
    1. Parvizi J, Della Valle CJ. AAOS clinical practice guideline: Diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg. 2010;18:771–2.
    1. Alijanipour P, Adeli B, Hansen EN, Chen AF, Parvizi J. Intraoperative purulence is not reliable for diagnosing periprosthetic joint infection. J Arthroplasty. 2015;30:1403–6. doi: 10.1016/j.arth.2015.03.005.
    1. Bingham J, Clarke H, Spangehl M, Schwartz A, Beauchamp C, Goldberg B. The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin Orthop Relat Res. 2014;472:4006–9. doi: 10.1007/s11999-014-3900-7.
    1. Gollwitzer H, Dombrowski Y, Prodinger PM, Peric M, Summer B, Hapfelmeier A, et al. Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am. 2013;95:644–51. doi: 10.2106/JBJS.L.00205.
    1. Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, et al. Circulating C reactive protein in osteoarthritis: A systematic review and meta-analysis. Ann Rheum Dis. 2015;74:703–10. doi: 10.1136/annrheumdis-2013-204494.
    1. Gewurz H, Mold C, Siegel J, Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med. 1982;27:345–72.
    1. Leeflang MM, Deeks JJ, Takwoingi Y, Macaskill P. Cochrane diagnostic test accuracy reviews. Syst Rev. 2013;2:82. doi: 10.1186/2046-4053-2-82.
    1. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36. doi: 10.7326/0003-4819-155-8-201110180-00009.
    1. Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg. 2011;39:91–2. doi: 10.1016/j.jcms.2010.11.001.
    1. Zhang K, Cui J, Xi H, Bian S, Ma L, Shen W, et al. Serum HER2 is a potential surrogate for tissue HER2 status in gastric cancer: A systematic review and meta-analysis. PLoS One. 2015;10:e0136322. doi: 10.1371/journal.pone.0136322.
    1. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58:982–90. doi: 10.1016/j.jclinepi.2005.02.022.
    1. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Diagnosing periprosthetic joint infection: Has the era of the biomarker arrived?Clin Orthop Relat Res. 2014;472:3254–62. doi: 10.1007/s11999-014-3543-8.
    1. Vanderstappen C, Verhoeven N, Stuyck J, Bellemans J. Intra-articular versus serum C-reactive protein analysis in suspected periprosthetic knee joint infection. Acta Orthop Belg. 2013;79:326–30.
    1. Buttaro MA, Martorell G, Quinteros M, Comba F, Zanotti G, Piccaluga F. Intraoperative synovial C-reactive protein is as useful as frozen section to detect periprosthetic hip infection. Clin Orthop Relat Res. 2015;473:3876–81. doi: 10.1007/s11999-015-4340-8.
    1. Tetreault MW, Wetters NG, Moric M, Gross CE, Della Valle CJ. Is synovial C-reactive protein a useful marker for periprosthetic joint infection? Clin Orthop Relat Res. 2014;472:3997–4003. doi: 10.1007/s11999-014-3828-y.
    1. Parvizi J, McKenzie JC, Cashman JP. Diagnosis of periprosthetic joint infection using synovial C-reactive protein. J Arthroplasty. 2012;27(8 Suppl):12–6. doi: 10.1016/j.arth.2012.03.018.
    1. Parvizi J, Jacovides C, Adeli B, Jung KA, Hozack WJ, Mark B. Coventry award: Synovial C-reactive protein: A prospective evaluation of a molecular marker for periprosthetic knee joint infection. Clin Orthop Relat Res. 2012;470:54–60. doi: 10.1007/s11999-011-1991-y.
    1. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Combined measurement of synovial fluid a-defensin and C-reactive protein levels: Highly accurate for diagnosing periprosthetic joint infection. J Bone Joint Surg Am. 2014;96:1439–45. doi: 10.2106/JBJS.M.01316.
    1. Beaule PE, Shea B, Abedlbary H, Ahmadzai N, Skidmore B, Mallick R, et al. A protocol for a systematic review of the diagnostic accuracy of blood markers, synovial fluid, and tissue testing in periprosthetic joint infections (PJI) Syst Rev. 2015;4:148. doi: 10.1186/s13643-015-0124-1.
    1. Parvizi J, Adeli B, Zmistowski B, Restrepo C, Greenwald AS. Management of periprosthetic joint infection: The current knowledge: AAOS exhibit selection. J Bone Joint Surg Am. 2012;94:e104. doi: 10.2106/JBJS.K.01417.
    1. Liao YY, Lin YM. The value of intraoperative gram stain in revision total knee arthroplasty. J Bone Joint Surg Am. 2010;92:1323.
    1. Parvizi J, Jacovides C, Zmistowski B, Jung KA. Definition of periprosthetic joint infection: Is there a consensus? Clin Orthop Relat Res. 2011;469:3022–30. doi: 10.1007/s11999-011-1971-2.
    1. Cats-Baril W, Gehrke T, Huff K, Kendoff D, Maltenfort M, Parvizi J. International consensus on periprosthetic joint infection: Description of the consensus process. Clin Orthop Relat Res. 2013;471:4065–75. doi: 10.1007/s11999-013-3329-4.
    1. Shahi A, Deirmengian C, Higuera C, Chen A, Restrepo C, Zmistowski B, et al. Premature therapeutic antimicrobial treatments can compromise the diagnosis of late periprosthetic joint infection. Clin Orthop Relat Res. 2015;473:2244–9. doi: 10.1007/s11999-015-4142-z.
    1. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, et al. New definition for periprosthetic joint infection: From the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–4. doi: 10.1007/s11999-011-2102-9.
    1. Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des. 2009;15:2377–92.
    1. Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016;387:386–94. doi: 10.1016/S0140-6736(14)61798-0.
    1. Cox N, Pilling D, Gomer RH. DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice. Proc Natl Acad Sci U S A. 2015;112:8385–90. doi: 10.1073/pnas.1500956112.
    1. Matsen Ko L, Parvizi J. Diagnosis of periprosthetic infection: Novel developments. Orthop Clin North Am. 2016;47:1–9. doi: 10.1016/j.ocl.2015.08.003.
    1. McArthur BA, Abdel MP, Taunton MJ, Osmon DR, Hanssen AD. Seronegative infections in hip and knee arthroplasty: Periprosthetic infections with normal erythrocyte sedimentation rate and C-reactive protein level. Bone Joint J. 2015;97-B:939–44. doi: 10.1302/0301-620X.97B7.35500.
    1. Ghanem E, Antoci V, Jr, Pulido L, Joshi A, Hozack W, Parvizi J. The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis. 2009;13:e444–9. doi: 10.1016/j.ijid.2009.02.017.
    1. Yuan K, Chen HL, Cui ZM. Diagnostic accuracy of C-reactive protein for periprosthetic joint infection: A meta-analysis. Surg Infect (Larchmt) 2014;15:548–59. doi: 10.1089/sur.2013.066.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅